Biomarkers of everolimus efficacy in breast cancer therapy.

Ioannis A Voutsadakis

Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2022)

Putative predictive biomarkers for everolimus efficacy in breast cancer patients, both genomic and clinical, deserve further study and could lead to a better selection of responsive patients.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
prognostic factors
cancer therapy
dna methylation
drug delivery
genome wide